Out-of-date browser detected
Your browser appears to be out-of-date, and portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to define a biosignature for increased risk of developing TB to: (i) accelerate clinical vaccine trials, (ii) facilitate design of preventive drug therapy and (iii) provide guidelines for improved diagnosis.
Grantee
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$1,762,708
Grant Topic
Tuberculosis
Duration (Months)
50
Grantee Location
München, Germany
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.